Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...
Immunic, Inc. to Participate in Scientific and Industry Conferences in April ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback